Dinah Sah

Dinah Sah is a highly experienced professional in the field of neuroscience and biotechnology, currently serving as Co-Executive Director at the Caribbean Science Foundation since February 2012 and as President and Director at CADSTI-NEW ENGLAND INC since April 2014. Dinah also holds positions on the Scientific Advisory Board and as Chief Scientific Officer at Voyager Therapeutics, Inc. until June 2024. Prior experience includes roles such as Senior Vice President, Neuroscience and Vice President of Research at Alnylam Pharmaceuticals from 2005 to 2012, and various research-related leadership roles at Biogen Idec (1999-2005) and Signal Pharmaceuticals (1993-1999). Dinah Sah holds a B.S. in Biology from the Massachusetts Institute of Technology and a Ph.D. in Neurobiology from Harvard University.